[Systematic preventive antibiotic therapy during hysterosalpingography in an African tropical environment: is this practice justified?].
To find out whether preventive antibiotic therapy can be justified in the practice of hysterosalpingography in a tropical environment where the infectious risk is notoriatly high, the authors performed a prospective study concerning 49 females patients. The patients in genital activity period, were willing and volunteers and were aged from 20 to 44 years. They were examined by hysterosalpingography during a period of three months. Patients were distributed in two homogenous group, one group of 25 patients who had a preventive antibiotic therapy and the second group with 24 patients with no preventive antibiotic therapy. Hysterosalpingography examinations were performed with sterile and single-use equipment. All patients were clinically examined for medical record purposes: gynaecologic, obstetric, pelvic infection, oral contraception, previous hysterosalpingography. Biologic dosages were realized, including blood count and erythrocyte sedimentation, culture of vaginal sampling, C reactive protein rate. The results obtained showed no significant difference between the two groups. The authors conclude that hysterosalpingography can be also performed in a tropical environment without using systematic preventive antibiotic therapy provided that asepsisrules are strictly observed.
N'Gbesso
Roger Daniel
RD
Service de radiologie, CHU de Yopougon, 21 BP 632, Abidjan 21, Cote d'Ivoire.
Tan
Bangali
B
Beddi
Mohamed Ould
MO
Quenum
Guillaume
G
D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000592:standards*; D001207:Asepsis / Q000379:methods; D007560:Cote d'Ivoire / Q000453:epidemiology; D003428:Cross Infection / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D003967:Diarrhea / Q000209:etiology; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D007047:Hysterosalpingography / Q000009:adverse effects*; D017053:Infection Control / Q000379:methods*; D018579:Patient Selection; D017699:Pelvic Pain / Q000209:etiology; D010406:Penicillins / Q000627:therapeutic use; D011322:Primary Prevention / Q000379:methods; D011446:Prospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014330:Tropical Medicine; D014592:Uterine Hemorrhage / Q000209:etiology
D010406:Penicillins; D000658:Amoxicillin